BenzophenoneCAS# 119-61-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 119-61-9 | SDF | Download SDF |
| PubChem ID | 3102 | Appearance | Powder |
| Formula | C13H10O | M.Wt | 182 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | diphenylmethanone | ||
| SMILES | C1=CC=C(C=C1)C(=O)C2=CC=CC=C2 | ||
| Standard InChIKey | RWCCWEUUXYIKHB-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C13H10O/c14-13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Benzophenone Dilution Calculator
Benzophenone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.4945 mL | 27.4725 mL | 54.9451 mL | 109.8901 mL | 137.3626 mL |
| 5 mM | 1.0989 mL | 5.4945 mL | 10.989 mL | 21.978 mL | 27.4725 mL |
| 10 mM | 0.5495 mL | 2.7473 mL | 5.4945 mL | 10.989 mL | 13.7363 mL |
| 50 mM | 0.1099 mL | 0.5495 mL | 1.0989 mL | 2.1978 mL | 2.7473 mL |
| 100 mM | 0.0549 mL | 0.2747 mL | 0.5495 mL | 1.0989 mL | 1.3736 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Benzoin
Catalog No.:BCC8854
CAS No.:119-53-9
- p-Anisoin
Catalog No.:BCC9113
CAS No.:119-52-8
- 7-Anilino-4-hydroxy-2-naphthalenesulfonic acid
Catalog No.:BCC8777
CAS No.:119-40-4
- Methyl salicylate
Catalog No.:BCN5372
CAS No.:119-36-8
- 8-Amino-2-naphthalenesulfonic acid
Catalog No.:BCC8783
CAS No.:119-28-8
- Viscumneoside III
Catalog No.:BCN7698
CAS No.:118985-27-6
- 1-O-Deacetyl-2alpha-hydroxykhayanolide E
Catalog No.:BCN1604
CAS No.:1189801-51-1
- Fumitremorgin C
Catalog No.:BCC7507
CAS No.:118974-02-0
- Mephedrone hydrochloride
Catalog No.:BCC6183
CAS No.:1189726-22-4
- Ethyl ganoderate J
Catalog No.:BCN3486
CAS No.:1189555-95-0
- (S,S)-2,6-Bis(4-isopropyl-2-oxazolin-2-yl)pyridine
Catalog No.:BCC8402
CAS No.:118949-61-4
- 1,3-Dihydroxy-4-methoxy-10-methylacridin-9(10H)-one
Catalog No.:BCN1605
CAS No.:1189362-86-4
- 2-Carboxybenzaldehyde
Catalog No.:BCN2274
CAS No.:119-67-5
- 5-Amino-2-naphthalenesulfonic acid
Catalog No.:BCC8732
CAS No.:119-79-9
- 3,4-Dihydrocoumarin
Catalog No.:BCN6793
CAS No.:119-84-6
- 2,2'-Biquinoline
Catalog No.:BCC8489
CAS No.:119-91-5
- Abiesinol F
Catalog No.:BCN6418
CAS No.:1190070-91-7
- 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide
Catalog No.:BCC8672
CAS No.:119018-29-0
- M2 ion channel blocker
Catalog No.:BCC1726
CAS No.:1190215-03-2
- Sarcandrone A
Catalog No.:BCN6073
CAS No.:1190225-47-8
- Sarcandrone B
Catalog No.:BCN6074
CAS No.:1190225-48-9
- PSI-7977
Catalog No.:BCC1871
CAS No.:1190307-88-0
- PSI-7976
Catalog No.:BCC5138
CAS No.:1190308-01-0
- EB 47
Catalog No.:BCC2452
CAS No.:1190332-25-2
Effect of Benzophenone-3 on performance, structure and microbial metabolism in an EGSB system.[Pubmed:30968737]
Environ Technol. 2019 Apr 10:1-31.
Benzophenone-3 is an organic compound widely used as a UV filter, which has been reported as water pollutant and is connected with endocrine disruption in humans and animals. Expanded granular sludge beds (EGSB) are a form of an anaerobic digestion system, which has been successfully evaluated for wastewater treatment, and the removal of different compounds, however little is known about the effect of compounds as Benzophenone-3 in the performance of EGSB systems. In this study, we evaluate the effect of BP-3 on the performance, microbial structure and metabolism of EGSB reactors. For this purpose, biogas production, removal efficiencies of BP-3 and DQO were monitored. Changes in bacteria and archaea microbial structure were investigated using PCR-DGGE, and the effect on anaerobic metabolism was evaluated by measuring the expression of mcrA and ACAs genes through qRT-PCR. The systems remained stable and efficient throughout the operation stages, with CH4 percentages greater than 55% and COD and BP-3 removal percentages greater than 90%. The presence of different concentrations of Benzophenone-3 influenced the organization of microbial communities, especially archaea. However, this did not affect the stability and performance of the EGSB systems.
The Relationship between Bulk Silicone and Benzophenone-Initiated Hydrogel Coating Properties.[Pubmed:30966568]
Polymers (Basel). 2018 May 16;10(5). pii: polym10050534.
Polydimethylsiloxane (PDMS) is a silicone elastomer-based material that is used in various applications, including coatings, tubing, microfluidics, and medical implants. PDMS has been modified with hydrogel coatings to prevent fouling, which can be done through UV-mediated free radical polymerization using Benzophenone. However, to the best of our knowledge, the properties of hydrogel coatings and their influence on the bulk properties of PDMS under various preparation conditions, such as the type and concentration of monomers, and UV treatment time, have never been investigated. Acrylate-based monomers were used to perform free radical polymerization on PDMS surfaces under various reaction conditions. This approach provides insights into the relationship between the hydrogel coating and bulk properties of PDMS. Altering the UV polymerization time and the monomer concentration resulted in different morphologies with different roughness and thickness of the hydrogel coating, as well as differences in the bulk material stiffness. The surface morphology of the coated PDMS was characterized by AFM. The cross section and thickness of the coatings were examined using scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy. The dependence of coating development on the monomer type and concentration used was evaluated by surface hydrophilicity, as measured by water contact angle. Elongation-until-break analysis revealed that specific reaction conditions affected the bulk properties and made the coated PDMS brittle. Therefore, boundary conditions have been identified to enable high quality hydrogel coating formation without affecting the bulk properties of the material.
Generation of Thymine Triplet State by Through-Bond Energy Transfer.[Pubmed:30920069]
Chemistry. 2019 Mar 28.
Benzophenone (BP) and drugs containing the BP chromophore, such as the non-steroidal antiinflammatory drug ketoprofen, have been widely reported as DNA photosensitizers via triplet-triplet energy transfer (TTET). In the present work, direct spectroscopic fingerprint for the formation of 3Thy* through-bond (TB) TTET from 3BP* is provided. This goal has been achieved in two new systems that have been designed and synthesized with one BP and one Thy covalently linked to both ends of the rigid skeleton of the natural bile acids cholic or lithocholic acid. The results shown here prove that it is possible to achieve triplet energy transfer to a Thy unit even when the photosensitizer is at a long (non-bonding) distance.
